Guidant Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Guidant Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$31K	Hold	236	–	–	0.01%	194
2019 Q2	$27K	Hold	236	–	–	0.01%	209
2019 Q1	$29K	Buy	236 +12	+5%	+$1.36K	0.01%	204
2018 Q4	$22K	Hold	224	–	–	0.01%	162
2018 Q3	$28K	Hold	224	–	–	0.01%	105
2018 Q2	$24K	Hold	224	–	–	0.01%	106
2018 Q1	$23K	Hold	224	–	–	0.01%	106
2017 Q4	$27K	Hold	224	–	–	0.01%	102
2017 Q3	$25K	Hold	224	–	–	0.02%	99
2017 Q2	$27K	Hold	224	–	–	0.01%	139
2017 Q1	$26K	Hold	224	–	–	0.01%	129
2016 Q4	$25K	Hold	224	–	–	0.01%	118
2016 Q3	$28K	Buy	+224	New	+$27.7K	0.02%	111

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Guidant Wealth Advisors's ZBH Position: Q3 2019 in Review

Guidant Wealth Advisors held its Zimmer Biomet (ZBH) position steady in Q3 2019 at 236 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #194.

Guidant Wealth Advisors first reported a position in ZBH in Q3 2016 and has held it in 13 quarters since. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Guidant Wealth Advisors held 236 shares of Zimmer Biomet worth $31K as of Q3 2019.
Guidant Wealth Advisors left its Zimmer Biomet share count unchanged in Q3 2019.
Zimmer Biomet made up 0.01% of Guidant Wealth Advisors's portfolio in Q3 2019, its #194 holding.
Guidant Wealth Advisors first reported a position in Zimmer Biomet in Q3 2016 and has held it in 13 quarters since.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Guidant Wealth Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.